Connection

Amy Sion to Carcinoma, Renal Cell

Back to Details
This is a "connection" page, showing publications Amy Sion has written about Carcinoma, Renal Cell.
Amy Sion
Connection Strength
0.629
Carcinoma, Renal Cell
  1. Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials. J Oncol Pharm Pract. 2020 Jun; 26(4):861-865.
    View in: PubMed
    Score: 0.629
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.